The use of subretinal triamcinolone acetonide in the management of neovascular age-related macular degeneration: a pilot study.

BACKGROUND: We conducted this study to investigate the toxicity and efficacy of pars plana vitrectomy combined with a single dose of sub-retinally administered triamcinolone acetonide (4 mg) in patients with subfoveal choroidal neovascular membranes secondary to age-related macular degeneration (AMD). METHODS: The important eligibility criteria included eyes with recent and progressive onset of decreased vision (